BLOG / 🇮🇳 India / broad market · · monthly

India Pre-Market Regulatory Roundup — July 30, 2026

India Before-Market Intelligence

By Gunpowder Editorial ·

10 high priority 40 medium priority 50 total filings analysed

Executive Summary

This digest covers 50 filings from July 29-30, 2026, revealing a market with sharp divergences. While the IT sector shows a worrying trend of revenue growth failing to translate to profit growth (Hexaware, Syngene), the energy and financial sectors are delivering record performances (Adani Power, OnEMI).

A major theme is the significant corporate restructuring underway, highlighted by ChrysCapital's controlling stake acquisition in Novartis India and UPL's composite scheme receiving exchange approvals. However, governance and compliance failures are stark, with Hampton Sky Realty facing a promoter demat freeze and ICSA India filing belated, zero-revenue results post-liquidation. The most critical development for immediate market action is Syngene's massive 16% revenue decline and guidance for a full-year degrowth, a stark contrast to the broad-based growth seen in Piramal Pharma and Laxmi Organic. Portfolio-level analysis shows a clear 'haves and have-nots' dynamic, with capital allocation favoring expansion (Rainbow Children's new hospital) over shareholder returns, as no major buybacks were announced. The overall sentiment is cautiously optimistic, but the number of high-materiality negative events (Syngene, Hampton Sky, ICSA) warrants selective stock-picking over a broad market approach.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Corporate governance · M&A · Company update · IPO · Insolvency

Tracking the trend? Catch up on the prior India Pre-Market Regulatory Roundup digest from July 22, 2026.

Investment Signals (10)

  • Record Q1 with PAT up 47% YoY to INR4,867 Cr, highest-ever generation of 31 BU, and PLF improving to 78% from 67% YoY. A 25-year PPA with Maharashtra DISCOM provides long-term revenue visibility.

  • Revenue surged 40% YoY to ₹9,683 Mn, with EBITDA up 272% YoY. The Dahej Phase I commercial deliveries have started, and exports now contribute 32% of revenue (up from 30% in FY26).

  • AUM crossed ₹8,001 Cr, up 61% YoY, with PAT growing 59% YoY to ₹95 Cr. The successful IPO in May 2026 and infusion of ~₹637 Cr into its NBFC subsidiary provides a strong capital base for growth.

  • Revenue grew 17% YoY with broad-based growth across all three businesses (CDMO +19%, CHG +17%, PCH +15%). EBITDA surged 72% YoY, with margins expanding ~400 bps to 12.5%, indicating strong operating leverage.

  • ChrysCapital's acquisition of a 70.68% controlling stake marks a significant vote of confidence in the Indian pharma sector. The new management and royalty-free brand licenses provide a clean slate for a turnaround.

  • Revenue grew 14.3% YoY and 4.0% sequentially, with adjusted PAT up 14.7% YoY. Operating margins remained healthy at 17.5%, and DSO improved to 92 days, showing strong execution.

  • Revenue grew 17.9% YoY, but PAT declined 13.0% YoY. The company reduced its CY26 revenue growth guidance to 6-7% (from 7.6%) due to delayed deal ramps, signaling a cautious outlook.

  • Revenue fell 16% YoY to Rs 736 Cr, with operating EBITDA margin halving to 12% from 24%. The company reported a net loss of Rs 9 Cr and guided for a full-year revenue decline, a major deterioration.

  • ADF Foods (BEARISH)

    While revenue grew 25.9% YoY, all key metrics declined sharply QoQ (Revenue -15%, PAT -33.3%). Standalone PAT margin dropped 490 bps QoQ to 15.1%, indicating significant seasonality and margin pressure.

  • BSE has directed depositories to freeze promoters' demat accounts due to failure to submit audited FY26 results, a severe governance failure that will severely impact investor confidence.

Risk Flags (10)

  • Revenue declined 16% YoY, EBITDA margin halved to 12%, and the company posted a net loss. Management's guidance for a full-year revenue decline is a major red flag for the sector.

  • Promoters' demat accounts frozen by BSE for non-compliance with financial reporting. This is a severe governance failure that could lead to further regulatory action and a loss of investor trust.

  • Filed belated financials showing zero revenue and persistent losses for periods from FY2019-20 to FY2022-23, following NCLT-ordered liquidation. The company is effectively dead, posing a total loss risk for remaining shareholders.

  • PAT declined 13.0% YoY despite 17.9% revenue growth. The company cut its CY26 revenue guidance, and employee costs grew faster than revenue (18.8% vs 17.9%), signaling margin pressure.

  • Received a Form 483 with 3 observations from the USFDA following a PAI and GMP inspection. This could delay product approvals and lead to increased regulatory scrutiny, impacting the pipeline.

  • A PIT violation occurred when a designated person's pledged shares were invoked during a trading window closure. While the quantum is small, it highlights risks in promoter pledging and compliance gaps.

  • The auditor issued a qualified conclusion due to the absence of impairment assessment on a recoverable amount of ₹79,993.47 lakh. The divestment of its material subsidiary for nil upfront consideration is also a concern.

  • The company's overall bed utilisation stands at only 46.3%, and the subsidiary for the new Malad hospital has a negative net worth. The investment is a bet on future demand, not current performance.

  • The company is raising up to ₹179 Cr in loans from the MD and promoter group, indicating severe financial stress and an inability to secure conventional bank financing.

  • PAT margin declined 120 bps YoY and 290 bps QoQ. The company cited geopolitical uncertainties and elevated freight costs as headwinds, which could persist and further compress margins.

Opportunities (10)

  • Adani Power (OPPORTUNITY)

    The company is a prime beneficiary of India's rising power demand (peak demand hit ~271 GW). The 25-year PPA with Maharashtra provides earnings visibility, and the acquisition of Jaiprakash Associates' power assets adds capacity.

  • With a 40% YoY revenue surge and Dahej Phase I commercial deliveries starting, the company is in a high-growth phase. The shift towards exports (32% of revenue) and specialty chemicals provides a strong growth runway.

  • Novartis India (OPPORTUNITY)

    The ChrysCapital acquisition provides a catalyst for a turnaround. The new management, royalty-free brand licenses, and a five-year distribution agreement create a clean slate. The stock could re-rate as the new strategy unfolds.

  • The company is a high-growth fintech play with AUM growing 61% YoY. The recent IPO and strong capital base provide fuel for growth. The key is to monitor if the modest uptick in GNPA (13 bps) is a trend or an outlier.

  • Piramal Pharma (OPPORTUNITY)

    The company is showing a clear path to profitability with EBITDA margins expanding 400 bps. The broad-based growth across all three segments (CDMO, CHG, PCH) de-risks the business model. The narrowing PAT loss is a positive sign.

  • The strategic partnership for a ₹6,000 Cr GDV project in Thane is a major catalyst. The project's focus on young professionals and families in a high-demand MMR micro-market offers significant revenue potential.

  • Midland Polymers (OPPORTUNITY)

    The acquisition of a 70% stake in a high-growth renewable energy company (turnover surged from ₹17.50 Lakh to ₹7,139.61 Lakh) provides a new growth vector. The share swap and preferential allotment structure is a creative financing method.

  • Lemon Tree Hotels (OPPORTUNITY)

    The signing of two new license agreements (Nepal and Vijayawada) expands the portfolio. The asset-light model of license agreements is capital-efficient and supports scalable growth in the booming hospitality sector.

  • Bajaj Housing Finance (OPPORTUNITY)

    The company highlighted a strong performance in AUM, disbursements, and asset quality at its AGM. The favorable outlook from India's 'Housing for All' initiatives provides a long-term tailwind for the housing finance sector.

  • Despite FX headwinds, the company delivered strong YoY growth in revenue (14.3%) and PAT (14.7%). The healthy operating margin of 17.5% and improved DSO suggest a well-managed, profitable growth story.

Sector Themes (6)

  • IT Sector: Growth-Profitability Paradox

    Both Hexaware and Syngene reported strong revenue growth (17.9% and -16% respectively, with Syngene being a negative outlier) but saw PAT decline. Hexaware's PAT fell 13% despite 17.9% revenue growth, while Syngene's margins halved. This suggests the sector is facing significant headwinds from rising employee costs, FX losses, and delayed deal ramps, making it a stock-picker's market.

  • Energy Sector: Record Performance on Power Demand

    Adani Power reported its highest-ever quarterly PAT (+47% YoY), driven by record power generation and a peak power demand of ~271 GW. This theme is supported by Laxmi Organic's strong performance, which is also tied to industrial activity. The energy value chain is a clear beneficiary of India's economic growth.

  • Financial Sector: Divergent Fortunes

    OnEMI Technology (fintech) is booming with 61% AUM growth, while traditional housing finance (Bajaj Housing) is stable. However, the high unsecured loan concentration (92.3%) at OnEMI is a risk. The sector is bifurcating between high-growth, high-risk fintech and stable, regulated NBFCs.

  • Corporate Restructuring & Governance Overhaul

    A major theme is the reshaping of corporate India. ChrysCapital's acquisition of Novartis India, UPL's composite scheme, and the board reshuffle at Midwest Gold signal a wave of strategic changes. Conversely, governance failures at Hampton Sky and ICSA India highlight the risks of non-compliance, creating a 'flight to quality' dynamic.

  • Consumer Staples: Margin Pressure Amidst Growth

    ADF Foods reported strong 25.9% YoY revenue growth, but PAT margins declined both YoY and QoQ due to elevated freight costs and geopolitical uncertainties. This suggests that even in a high-growth consumer environment, companies are struggling to protect their bottom lines from global input cost inflation.

  • Healthcare: Expansion vs. Utilization

    Rainbow Children's Medicare is investing heavily in new capacity (Malad, Pune), but its current bed utilization is only 46.3%. This creates a risk of capital being tied up in underutilized assets for an extended period, a key metric to watch for the company's return on capital employed.

Watch List (8)

  • Watch for Q2 FY27 results to see if the revenue decline stabilizes and if EBITDA margins begin to recover towards the mid-20s as guided. The new CEO's strategy will be critical.

  • Monitor for the submission of audited FY26 financial results. The lifting of the promoter demat freeze is the key catalyst for a potential stock recovery, but failure to comply could lead to further regulatory action.

  • Watch for the new management's strategic roadmap under ChrysCapital. The adoption of a new name and corporate identity, along with the first full quarter of standalone results, will be key catalysts.

  • Monitor the company's response to the USFDA Form 483. Any subsequent warning letter or delay in product approvals from the Srikakulam facility would be a significant negative.

  • The outcome of the shareholder vote on the divestment of Liberium Global Resources is critical. Also, watch for any resolution of the auditor's qualified opinion regarding the ₹79,993.47 lakh recoverable amount.

  • The company's ability to raise the proposed ₹179 Cr in loans from the MD and promoter group is a key test of its financial viability. Failure to do so could signal a deepening crisis.

  • The key metric to watch is asset quality. A continued uptick in GNPA (currently 2.25%) or NNPA (0.36%) would be a major red flag for this high-growth fintech lender.

  • The commissioning of the acquired Jaiprakash Associates' power assets and the ramp-up of the 1,600 MW PPA with Maharashtra DISCOM will be key drivers of future earnings growth.

Filing Analyses (50)
Aequs Ltd Analyst/Investor Meet neutral materiality 1/10

29-07-2026

Aequs Ltd has informed the stock exchanges that the audio recording of its earnings conference call for the unaudited financial results of Q1 FY27 (quarter ended June 30, 2026) is now available on the company's website. The call was held on July 29, 2026, at 6:00 p.m. IST. This is a routine regulatory disclosure and contains no financial figures or performance data.

  • · The audio recording is available at https://www.aequs.com/wp-content/uploads/2026/07/Earnings-Call-Audio-Q1-FY-27.mp3
  • · The filing is made under SEBI Regulations 30 and 46 of the Listing Regulations
Midwest Gold Ltd Corporate Governance neutral materiality 7/10

29-07-2026

Midwest Energy Ltd (formerly Midwest Gold Ltd) announced a major board reshuffle at its July 28, 2026 board meeting. Four directors resigned, including whole-time director Deepak Kukreti, and the CFO Palepu Ramakrishna Venkatachala also resigned. The company appointed two new directors (Dinabandhu Mohapatra as Independent Director and Kollareddy Ranganayakamma as Non-Executive Director), a new CFO (Rama Devi Dasari), and approved a related-party consultancy fee of up to ₹12,50,000 per month plus GST to outgoing director Deepak Kukreti for renewable energy initiatives, subject to shareholder approval via postal ballot.

  • · Mr. Dinabandhu Mohapatra, former MD & CEO of Bank of India, appointed for a first term of five consecutive years as Non-Executive Independent Director, effective 28 July 2026, subject to shareholder approval.
  • · Mrs. Kollareddy Ranganayakamma, mother of promoter Soumya Kukreti, appointed as Non-Executive Director, liable to retire by rotation.
  • · New CFO Rama Devi Dasari is a qualified CA with LL.B. and has completed the Strategic Management Programme from IIM Ahmedabad, with nearly 20 years of experience including as Global Controller at Broadridge Financial Solutions (NYSE-listed, ~$4.5B revenue).
  • · All four resigned directors cited personal reasons/other professional commitments; no material reasons other than those stated.
  • · The related-party consultancy payment to Deepak Kukreti requires shareholder approval via a Special Resolution through Postal Ballot.
UPL Limited Merger/Acquisition neutral materiality 8/10

29-07-2026

UPL Limited has received 'no adverse observations' letters from BSE and NSE dated July 29, 2026, regarding its Composite Scheme of Arrangement involving UPL Sustainable Agri Solutions Limited, UPL Global Sustainable Agri Solutions Limited, and UPL Crop Protection Holdings Limited. The stock exchanges have imposed several conditions, including disclosure of pending adjudication proceedings, compliance with SEBI circulars, and ensuring financials in the scheme are not more than 6 months old. The scheme remains subject to other regulatory approvals, and the observation letters are valid for six months.

  • · The observation letters from BSE and NSE are dated July 29, 2026.
  • · The scheme involves four entities: UPL Limited (UPL 1), UPL Sustainable Agri Solutions Limited (UPL SAS), UPL Global Sustainable Agri Solutions Limited (UPL 2), and UPL Crop Protection Holdings Limited (UPL Cayman 1).
  • · The company must disclose all details of ongoing adjudication, recovery proceedings, and enforcement actions against itself, promoters, and directors before NCLT and shareholders.
  • · Financials in the scheme, including those for valuation, must not be more than 6 months old.
  • · The listing of equity shares of UPL Global Sustainable Agri Solutions Limited is subject to SEBI granting relaxation under Rule 19(2)(b) of the Securities Contract (Regulation) Rules, 1957.
  • · The validity of the observation letter is six months from July 29, 2026, within which the scheme must be submitted to NCLT.
  • · The company must publish an advertisement with details of UPL Global Sustainable Agri Solutions Limited in newspapers.
  • · Shares allotted pursuant to the scheme shall remain frozen in the depository system until listing/trading permission is given.
Prestige Estates Projects Limited Market Notice positive materiality 6/10

29-07-2026

Prestige Group has entered a strategic partnership to develop a landmark residential project in Thane, MMR, with an estimated GDV of ₹6,000 Crore. The project spans approximately 14.6 acres with over 5 million square feet of developable potential, targeting young professionals, first-time buyers, and families. The filing is a routine market disclosure and does not contain any negative or flat performance metrics.

  • · The project is located near Kolshet–Balkum Road in Thane, offering connectivity to business districts, road networks, educational institutions, and healthcare facilities.
  • · The development will include a retail component, creating a live-work-shop environment.
  • · The project will be developed in phases, subject to statutory and regulatory approvals.
  • · Prestige Group has delivered 316 projects spanning 212 million sqft and has a pipeline of 135 projects across 227 million sqft as of March 2026.
Piramal Pharma Limited Market Notice mixed materiality 8/10

29-07-2026

Piramal Pharma Limited reported consolidated revenue of ₹2,270 Cr for Q1 FY27, up 17% YoY from ₹1,934 Cr in Q1 FY26, driven by broad-based growth across all three businesses (CDMO +19%, CHG +17%, PCH +15%). EBITDA surged 72% to ₹285 Cr with margin expanding ~400 bps to 12.5%, reflecting improved operating leverage and execution. However, the company remained net loss-making with a PAT loss of ₹69 Cr (vs ₹82 Cr loss in Q1 FY26, an improvement of 15%), and tax expense spiked 2,211% to ₹62 Cr, significantly impacting bottom line.

  • · Material cost grew 23% YoY, outpacing revenue growth of 17%, indicating input cost pressure.
  • · Employee expenses rose 9% YoY and other expenses rose 6% YoY, partially offsetting operating leverage gains.
  • · Interest expense remained nearly flat at ₹88 Cr (up 2% YoY), while depreciation increased 13% to ₹224 Cr.
  • · Tax expense surged to ₹62 Cr from ₹3 Cr in Q1 FY26, a 2,211% increase, significantly impacting net profit.
  • · PCH e-commerce grew 40% YoY and contributed 28% of sales; Power Brands grew 23% YoY and contributed 53% of sales.
  • · CDMO business inaugurated a commercial-scale payload-linker suite at Riverview (US) and Lexington sterile injectable capacity expansion is on track.
  • · Sellersville facility received an Establishment Inspection Report (EIR) from US FDA, maintaining Zero OAI status.
  • · Kenalog supplies expected to start from Q2 FY27.
  • · Conference call for investors/analysts scheduled for 30th July 2026 from 9:30 AM to 10:15 AM IST.
ELITECON INTERNATIONAL LIMITED Market Notice negative materiality 2/10

29-07-2026

Elitecon International Limited informed stock exchanges that Mr. Kumar Anubhav Upadhyay ceased as Additional Director effective July 29, 2026, because the company failed to obtain shareholder approval within the three-month period required under SEBI Listing Regulations. The cessation is a regulatory compliance matter but does not involve any financial penalties or operational changes.

  • · Mr. Upadhyay was appointed as Additional Director on April 29, 2026, and ceased on July 29, 2026.
  • · The company did not obtain shareholder approval within the prescribed timeline under Regulation 17(1C) of SEBI Listing Regulations.
  • · Mr. Upadhyay also holds a Whole-time Director position at Centuple Global Limited.
Happiest Minds Technologies Limited Corporate Governance positive materiality 8/10

29-07-2026

Happiest Minds Technologies reported a strong start to FY27 with operating revenue of ₹629 crore, up 14.3% YoY and 4.0% sequentially. Adjusted PAT grew 14.7% YoY to ₹80.5 crore, while operating margins remained healthy at 17.5%. However, constant currency revenue growth was a more modest 6.7% YoY, and US dollar revenue grew only 2.9% YoY, reflecting headwinds from foreign exchange movements and a selective demand environment.

  • · Revenue in US$ terms grew only 2.9% YoY and 1.7% sequentially, highlighting FX headwinds.
  • · Utilization rate declined to 81% from 82% in the prior quarter.
  • · DSO improved to 92 days.
  • · Repeat business was 94.4% of revenues.
  • · Billion-dollar corporations contributed 58.7% of revenues.
  • · Key wins include a multi-year, multi-million-dollar Managed Security Services deal with a Middle Eastern retailer and a strategic Data & AI partnership with a N. American energy infrastructure company.
  • · Ashok Soota was recognized among AIM 100: India's Most Influential People Shaping AI in 2026.
  • · Preeti Menon was recognized among AIM: The Top 24 Women Enterprise AI Leaders in India.
Hexaware Technologies Limited Corporate Governance mixed materiality 8/10

29-07-2026

Hexaware Technologies reported Q2 CY2026 consolidated revenue of ₹38,452 million, up 17.9% YoY from ₹32,607 million, driven by growth in Healthcare & Insurance (+32.0%), Manufacturing & Consumer (+31.1%), and Financial Services (+12.7%). However, profit after tax declined 13.0% YoY to ₹3,302 million, impacted by lower other income and higher employee costs. For H1 2026, revenue rose 15.3% YoY to ₹74,582 million, while PAT fell 3.5% to ₹6,818 million.

  • · Total employee benefits expense for Q2 2026 was ₹22,664 million, up 18.8% YoY
  • · Other expenses for Q2 2026 rose 2.6% YoY to ₹9,735 million
  • · Finance costs for Q2 2026 increased 56.9% YoY to ₹328 million
  • · Depreciation and amortisation for Q2 2026 increased 8.6% YoY to ₹817 million
  • · Effective tax rate for Q2 2026 was 25.1% vs 18.9% in Q2 2025
  • · Total comprehensive income for Q2 2026 increased 3.5% YoY to ₹4,271 million
  • · Interim dividend for H1 2026 raised to ₹8.50 per share vs ₹5.75 in H1 2025 (47.8% increase)
  • · Paid-up equity share capital: 610 million shares of ₹1 each
Piramal Pharma Limited Market Notice mixed materiality 8/10

29-07-2026

Piramal Pharma Limited reported consolidated Q1 FY27 revenue of ₹2,270 Cr, up 17% YoY from ₹1,934 Cr, driven by broad-based growth across all three businesses (CDMO +19%, CHG +17%, PCH +15%). EBITDA surged 72% to ₹285 Cr with margin expanding ~400 bps to 12.5%, reflecting improved operating leverage and execution. However, the company remained net loss-making with PAT (after exceptional items) of (₹69) Cr, though this was a 15% improvement from (₹82) Cr in Q1 FY26.

  • · Company remains net loss-making at (₹69) Cr PAT after exceptional items, though loss narrowed 15% YoY.
  • · Interest expenses remained nearly flat at ₹88 Cr (up only 2% YoY), but depreciation increased 13% to ₹224 Cr.
  • · Tax expense surged to ₹62 Cr from just ₹3 Cr in Q1 FY26, a 2,211% increase, significantly impacting bottom line.
  • · Material costs grew 23% YoY, outpacing revenue growth, indicating input cost pressures.
  • · PCH e-commerce grew 40% YoY and now contributes 28% of Consumer Healthcare sales; Power Brands grew 23% YoY and contribute 53% of sales.
  • · CDMO business saw improved biopharma funding increasing RFPs, but customer decision-making timelines remain prolonged.
  • · Sellersville facility received an Establishment Inspection Report (EIR) from US FDA; company maintains Zero OAI status to date.
  • · Kenalog supplies expected to start from Q2 FY27.
  • · Company has 171 global facilities and distribution network in over 100 countries.
  • · Conference call for investors/analysts scheduled for 30th July 2026 from 9:30 AM to 10:15 AM IST.
Vedanta Iron And Steel Ltd Market Notice positive materiality 6/10

29-07-2026

Vedanta Iron And Steel Ltd has informed the exchanges that CRISIL Ratings has assigned a 'Crisil AA/Stable' rating to its proposed banking facility. The rating action was published on July 29, 2026, and the detailed rationale is available on CRISIL's website.

  • · Rating assigned: Crisil AA/Stable
  • · Facility rated: Proposed banking facility
  • · Rating outlook: Stable
  • · Rating agency: CRISIL Ratings Limited
  • · Disclosure made under Regulation 30 of SEBI Listing Regulations
Syngene International Limited Corporate Governance neutral materiality 3/10

29-07-2026

Syngene International Limited held its 33rd Annual General Meeting on July 29, 2026 via video conferencing, with 117 members present. The meeting approved nine resolutions including adoption of audited financial statements, a final dividend of ₹1.25 per equity share, appointment of new statutory auditors (S.R. Batliboi & Associates LLP), and appointment of two new independent directors (Dr. Vijaya Chandru and Dr. Arun Chandavarkar). No financial performance details or period-over-period comparisons were disclosed in this filing.

  • · The meeting was held via Video Conferencing / Other Audio-Visual Means in compliance with MCA and SEBI circulars.
  • · Remote e-voting was open from July 24, 2026 (9:00 am IST) to July 28, 2026 (5:00 pm IST); Instapoll facility was available for 15 minutes after the AGM.
  • · The scrutinizer's report will be submitted to stock exchanges within two working days and posted on company and exchange websites.
  • · The meeting commenced at 3:31 PM IST and concluded at 4:33 PM IST.
Maharashtra Scooters Limited Corporate Governance neutral materiality 3/10

29-07-2026

Maharashtra Scooters Limited held its 51st Annual General Meeting on July 29, 2026, via video conferencing. The meeting approved the audited financial statements for FY2026, declared a final dividend of ₹60 per equity share (face value ₹10), and re-appointed director Ravikumar Srinivasan. The filing does not disclose any financial performance metrics, so no positive or negative trends can be assessed.

  • · The AGM was held via video conferencing in compliance with MCA and SEBI circulars.
  • · The auditors' reports for FY2026 contained no adverse remarks, qualifications, or disclaimers.
  • · The meeting lasted from 10:45 a.m. to 11:41 a.m. (56 minutes).
  • · E-voting results and the Scrutiniser's Report will be filed with exchanges within two working days.
Honeywell Automation India Limited Corporate Governance mixed materiality 5/10

29-07-2026

Honeywell Automation India Limited held its 42nd Annual General Meeting on July 29, 2026, via video conference, and all seven resolutions were passed with the requisite majority. Routine items such as adoption of financial statements, a final dividend of ₹110 per share, and re-appointment of director Ashish Kumar Modi received near-unanimous approval. However, the two material related party transactions (RPTs) with Honeywell International Inc. and Honeywell Measurex (Ireland) Limited saw significant dissent, with 12.45% of public institutional votes cast against each, and overall voting turnout on those resolutions was only 13.74% because the promoter group abstained.

  • · The AGM was held via video conference and lasted from 4:00 PM to 5:10 PM IST.
  • · Record date for voting was July 22, 2026.
  • · No shareholders attended in person or by proxy; all 42 attendees joined via video conferencing.
  • · Promoter group held 6,631,142 shares (75.0% of total equity) and voted in favour of all resolutions except the two RPTs where they abstained.
  • · Resolution 4 (commission to Dr. Ganesh Natarajan) saw 10.24% dissent from public non-institutional shareholders.
  • · Resolution 3 (re-appointment of Ashish Kumar Modi) saw 5.51% dissent from public non-institutional shareholders.
  • · No invalid votes were recorded for any resolution.
Laxmi Organic Industries Limited Market Notice positive materiality 8/10

29-07-2026

Laxmi Organic Industries reported a strong Q1 FY27 with revenue of ₹9,683 Mn, up 40% YoY from ₹6,929 Mn, driven by double-digit growth across both Essentials (+50%) and Specialties (+17%) segments. EBITDA surged 272% YoY to ₹1,143 Mn and PAT rose 216% to ₹677 Mn, supported by higher realizations and operating leverage. However, the company cautioned that markets remain volatile due to geopolitical disturbances impacting feedstock prices and supply chain, and employee costs remained flat at ₹398 Mn.

  • · Exports contributed 32% of revenue in Q1 FY27, up from 30% in FY26.
  • · Top 10 customers accounted for 20% of revenue in Q1 FY27, down from 23% in FY26.
  • · Dahej Phase I commercial deliveries started; Phase II commissioning is the next milestone.
  • · Mahad Site I scheduled maintenance successfully completed during the quarter.
  • · Employee cost decreased slightly YoY from ₹409 Mn to ₹398 Mn.
  • · Power & fuel costs increased 26% YoY to ₹766 Mn; other expenses rose 62.8% to ₹1,320 Mn.
  • · The company has 4 manufacturing sites with total asset base of ~₹21,000 Mn.
  • · Green power constitutes ~25% of total power consumption.
  • · R&D team of 65+ scientists and engineers; new Innovation Centre in Mahape inaugurated Feb 2025 with $8 Mn investment.
  • · Board includes 10 directors with diverse backgrounds; management team of 8 senior executives.
Adani Ports and Special Economic Zone Limited Company Update neutral materiality 1/10

30-07-2026

Adani Ports and SEZ disclosed the audio recording link for its analyst/investor call held on July 29, 2026, regarding the unaudited financial results for the quarter ended June 30, 2026. The filing provides the audio link and confirms the call concluded at 7:21 PM IST. No financial figures or performance comparisons are included in this disclosure.

  • · Audio recording link: https://www.adaniports.com/-/media/project/ports/investor/investor-downloads/earningscallaudio/10044677.mp3
  • · Call concluded at 7:21 PM IST on July 29, 2026
Hexaware Technologies Limited Market Update mixed materiality 8/10

29-07-2026

Hexaware Technologies reported Q2CY26 revenue of INR 38,452 Mn (USD 405.4 Mn), up 6.4% QoQ and 17.9% YoY in INR terms, with constant currency growth of 4.4% QoQ and 6.3% YoY. EBIT margin improved 33 bps QoQ to 13.6%, but PAT declined 6.1% QoQ and 13.0% YoY to INR 3,302 Mn, impacted by higher finance costs and other income losses. The company added one USD 20Mn+ customer and closed headcount at 34,506 with net addition of 708.

  • · Q2CY26 EBIT margin improved 33 bps QoQ to 13.6%, but declined 102 bps YoY.
  • · Voluntary attrition for IT at 11.2%.
  • · Utilization rate for IT at 84.8% (Q2CY26), improved 80 bps due to exclusion of platform employees.
  • · DSO (Billed + Unbilled) at 78 days.
  • · LTM Q2CY26 Operating Cash Flow to Reported Profit % at 124.7%.
  • · Cash and cash equivalents (including restricted and MF investments) at USD 176 Mn as of Jun 30, 2026.
  • · Top 10 customer revenue concentration at 35.7% (LTM basis).
  • · Revenue growth by vertical: Healthcare & Insurance +18.9% YoY, Manufacturing & Consumer +17.9% YoY, Professional Services -3.4% YoY, Travel & Transportation -14.5% YoY.
  • · Revenue growth by geography: Americas +3.5% YoY, Europe +10.9% YoY, Asia Pacific +24.8% YoY.
  • · Acquisition of Consulting Professionals Services Holdings Limited for GBP 6 Mn upfront plus contingent consideration up to GBP 5 Mn.
  • · Patent infringement claim by Natsoft Corporation and Updraft LLC dismissed by US District Court; plaintiffs granted opportunity to file amended complaint.
  • · Interim dividend of INR 8.50 per share declared on April 27, 2026 and paid on May 15, 2026.
  • · 449,976 equity shares issued during H1CY26 on exercise of employee stock options.
  • · 1,223,153 treasury shares held by controlled trust as at Jun 30, 2026.
Bajaj Housing Finance Limited Corporate Governance positive materiality 5/10

29-07-2026

Bajaj Housing Finance Limited held its 18th Annual General Meeting on July 29, 2026, via video conferencing, chaired by Sanjiv Bajaj. The meeting covered adoption of FY2026 financials, re-appointment of Rajeev Jain, approval for NCD issuance, and material related-party transactions with Bajaj Finance Limited. Management highlighted strong performance in AUM, disbursements, profitability, and asset quality, while noting the favorable outlook from India's housing growth and 'Housing for All' initiatives.

  • · The meeting commenced at 3:45 p.m. and concluded at 5:47 p.m. IST.
  • · Resolutions included adoption of FY2026 financial statements, re-appointment of Rajeev Jain, NCD issuance via private placement, and approval of material related-party transactions with Bajaj Finance Limited.
  • · Statutory and Secretarial Auditors' reports for FY2026 contained no adverse remarks or qualifications.
  • · The e-voting results and consolidated Scrutiniser's Report will be filed with exchanges within two working days and posted on the company's website.
Hexaware Technologies Limited Analyst/Investor Meet mixed materiality 8/10

29-07-2026

Hexaware Technologies reported Q2CY26 revenue of USD 405.4 Mn (INR 38,452 Mn), up 4.4% QoQ and 6.1% YoY in USD terms, driven by strong growth in Healthcare & Insurance (+18.9% YoY) and Asia Pacific (+24.8% YoY). However, EBIT margin declined 102 bps YoY to 13.6%, and Basic EPS fell 13.4% YoY to INR 5.41. The company reduced its CY26 revenue growth guidance to 6-7% (from 7.6%) due to delayed deal ramp and worsening macro, while reiterating EBIT margin guidance of 13.0%–14.0%.

  • · Q2CY26 constant currency revenue growth was 4.4% QoQ and 6.3% YoY.
  • · Q2CY26 reported EBIT margin was 13.6%, up 68 bps QoQ but down 102 bps YoY vs Q2CY25 adjusted EBIT of 14.7%.
  • · Q2CY26 reported profit was USD 35 Mn, down from USD 44 Mn in Q2CY25 and USD 37 Mn in Q1CY26.
  • · Q2CY26 Basic EPS was INR 5.41, down 6.2% QoQ and 13.4% YoY.
  • · Closing cash balance as of June 30, 2026 was USD 176 Mn.
  • · Voluntary attrition for IT was 11.2%, essentially flat QoQ.
  • · Utilization rate for IT was 84.8%, up from 82.6% in Q1CY26, partly due to a methodology change that improved utilization by 80 bps.
  • · DSO - Billed improved to 39 days from 44 days QoQ, but DSO - Unbilled increased to 36 days from 31 days.
  • · LTM OCF / Reported Profit cash conversion was 124.7%, slightly down from 125.1% in Q1CY26.
  • · Effective tax rate dropped to 18.9% from 25.1% in Q1CY26.
  • · Top 5 customers contributed 25.3% of LTM revenue (down from 25.8% in LTM Q2CY25), top 10 contributed 35.7% (down from 36.6%), and top 20 contributed 48.7% (down from 50.1%).
  • · Onsite IT services revenue mix was 48.0% and offshore was 52.0% in Q2CY26.
  • · The company expanded talent footprint to Colombia and added GIFT City to India footprint.
  • · CY26 vertical outlook: Healthcare & Insurance, Banking, and Manufacturing & Consumer expected to lead growth; Professional Services and Financial Services to follow; Travel & Transportation expected to lag.
  • · The company plans to host an AI Day on August 21, 2026 at its Chennai Campus.
OnEMI Technology Solutions Ltd Market Notice positive materiality 8/10

29-07-2026

OnEMI Technology Solutions Ltd (Kissht) reported Q1 FY27 results with AUM crossing ₹8,001 Cr, up 61% YoY and 13% QoQ, and PAT growing 59% YoY to ₹95 Cr. Asset quality remained strong with GNPA at 2.25%, a 139 bps YoY improvement, though with a modest 13 bps sequential increase. The company successfully listed on NSE and BSE in May 2026 and continues to scale its secured LAP portfolio, which now contributes 7.7% of AUM.

  • · Cumulative customers served reached 12.25 Mn, up 4% QoQ and 26% YoY.
  • · Active customers stood at 3.49 Mn, up 7% QoQ and 111% YoY.
  • · Credit rating of subsidiary NBFC (Si Creva) is A-/Stable.
  • · Capital Adequacy Ratio improved to 40.19%, up 1,491 bps QoQ and 1,478 bps YoY.
  • · Debt to Equity ratio improved to 0.91x, down from 1.78x QoQ and 1.55x YoY.
  • · RoAAUM was 5.05% (flat QoQ, down 23 bps YoY) and RoAE was 21.20% (down 411 bps QoQ and 168 bps YoY).
  • · Collection Efficiency (DPD 30) was 96.82%, down 33 bps both QoQ and YoY.
  • · PCR was 84.13%, down 202 bps QoQ and 653 bps YoY.
  • · NNPA was 0.36%, up 6 bps QoQ and 2 bps YoY.
  • · LAP AUM mix increased to 7.7% from 7.3% in Mar-26 and 2.5% in Jun-25.
  • · Average customer age is 32 years, median CIBIL score is 746.
  • · 78% of PL customers reside in top 100 cities, 53% are self-employed.
  • · 72% of users are under age 35.
  • · FOIR for newly acquired customers improved by 14% YoY.
  • · Customer share with 700+ CIBIL score improved to 95.5% in FY26 from 94.8% in FY25.
  • · Registered users grew 29% YoY to 68.55 Mn in FY26.
  • · Company listed on NSE and BSE on May 8, 2026.
KESAR INDIA LIMITED Merger/Acquisition neutral materiality 8/10

29-07-2026

Kesar India Limited has acquired 100% equity stake in Kesar Lands Private Limited (KLPL) for a total purchase consideration of ₹1,55,85,77,800 (₹155.86 Cr), to be paid via a share swap of up to 17,31,752 equity shares at ₹900 per share. KLPL, a related-party entity with zero turnover for the past three fiscal years, will become a wholly owned subsidiary. The acquisition aims to strengthen Kesar India's presence in real estate and infrastructure development.

  • · KLPL was incorporated on October 19, 2026 (note: this date appears to be a typo in the filing as it is after the filing date of July 29, 2026; the CIN suggests incorporation in 2010).
  • · KLPL's turnover for FY 2023-24, FY 2024-25, and FY 2025-26 was NIL.
  • · The acquisition is a related-party transaction as KLPL is a related party, and the promoter group (Yash Gopal Gupta and Sangeeta Gopal Gupta) holds 100% of KLPL.
  • · The share swap is subject to shareholder approval via a special resolution and in-principle approval from the stock exchange.
  • · Completion of the acquisition is expected within 15 days from the later of shareholder approval or receipt of the last regulatory approval.
Purple Wave Infocom Ltd Market Notice neutral materiality 3/10

29-07-2026

Purple Wave Infocom Ltd has issued a clarification to BSE regarding a significant movement in its share price, stating that the company has disclosed all material information in compliance with SEBI regulations and that the price movement is purely market-driven. The management disclaims any connection to the price movement and reiterates its commitment to regulatory compliance.

  • · The clarification was filed on July 29, 2026, in response to a price movement query from BSE.
  • · The company's scrip code on BSE is 544627.
  • · The company has offices in Delhi, Karnataka, Maharashtra, Assam, and Haryana.
  • · The company's CIN is L72300DL2007PLC170537.
Novartis India Limited. Market Update neutral materiality 9/10

29-07-2026

Novartis India Limited announced the completion of the sale of 17,450,680 equity shares from Novartis AG to ChrysCapital (WaveRise Investments Limited, ChrysCapital Fund X, and Two Infinity Partners), resulting in a change of control. The Board approved several key agreements, including a royalty-free license for the 'Tegrital' trademark and a trademark assignment for brands like Voveran, Macalvit, and Citromacalvit, as well as a five-year distribution agreement with Novartis Pharma Services AG. New leadership was appointed, including Dr. Vikas Gupta as Managing Director & CEO and Mr. Bhagwat Singh Deora as CFO, alongside the adoption of new corporate policies, a new email domain (nilpharma.co.in), and a new website (www.nilpharma.co.in).

  • · The Board meeting commenced at 07:15 PM and concluded at 08:30 PM on July 29, 2026.
  • · The Distribution Agreement has an initial term of five years, with an option to extend for an additional five years.
  • · The Tegrital brand license is exclusive, irrevocable, royalty-free, and non-assignable, with an automatic assignment to the Company at no additional cost.
  • · The Trademark Assignment and License Deed covers trademarks and logos such as Voveran, Macalvit, and Citromacalvit.
  • · New corporate policies adopted include Vigil Mechanism, CSR, Risk Management, and Insider Trading Code.
  • · Senior management appointments include a President for M&A, Business Development & Investor Relations, a CHRO, a Chief Supply Chain Officer, and a President for Business Operations.
Syngene International Limited Market Notice negative materiality 9/10

29-07-2026

Syngene International reported a sharp decline in Q1 FY27 performance, with revenue from operations falling 16% YoY to Rs 736 Cr and operating EBITDA margin dropping to 12% from 24% in Q1 FY26. Profit after tax before exceptional items was just Rs 1 Cr, and after exceptional items (Rs 10 Cr net of tax for termination benefits) the company posted a loss of Rs 9 Cr. The poor results were driven by lack of offtake from a major LMCDMO client and forex hedge losses, partially offset by cost optimization. Management expects a degrowth in H1 but a single-digit revenue decline for the full year with EBITDA margins recovering to the mid-20s.

  • · Siddharth Mittal assumed charge as MD & CEO on July 1, 2026.
  • · Signed MoU with BRIC-THSTI for joint operational partnership in clinical development, translational research and bioanalytical sciences.
  • · Featured in TIME Magazine and Statista's 'World's Most Sustainable Companies 2026' ranking for second consecutive year.
  • · Syngene has ~400 active clients, 16 of top 20 pharma companies are clients.
  • · Total headcount 8,373 including 5,778 scientists; 7% PhDs; 27% women overall, 19% women in senior management.
  • · Infrastructure of ~3 million sq ft across Bangalore, Mangalore, Hyderabad and Baltimore, USA.
  • · US FDA, EMA, UK VMD, Health Canada, PMDA approved, AAALAC accredited and GLP certified facilities.
  • · 92% of energy from renewable sources.
Hexaware Technologies Limited Market Notice mixed materiality 8/10

29-07-2026

Hexaware Technologies reported Q2CY26 revenue of USD 405.4 Mn (INR 38,452 Mn), up 4.4% QoQ and 6.1% YoY in USD terms, with EBIT margin improving 68 bps QoQ to 13.6%. However, Basic EPS declined 6.2% QoQ to INR 5.41, and EBIT margin fell 102 bps YoY versus the prior-year adjusted figure of 14.7%. The company reduced its CY26 revenue growth guidance to 6-7% (from 7.6%) due to delayed deal ramps and worsening macro conditions, while reiterating EBIT margin guidance of 13.0%-14.0%.

  • · Revenue mix: Onshore IT Services 48.0%, Offshore IT Services 52.0% in Q2CY26.
  • · DSO (billed) improved to 39 days in Q2CY26 from 44 days in Q1CY26; DSO (unbilled) was 36 days.
  • · LTM OCF / Reported Profit cash conversion was 124.7% in Q2CY26, down from 127.1% in Q1CY26.
  • · Effective tax rate dropped sharply to 10.4% in Q2CY26 from 25.1% in Q1CY26.
  • · Top 5 customers contributed 25.3% of LTM revenue (down from 25.8% in Q1CY26); Top 10 contributed 35.7%; Top 20 contributed 48.7%.
  • · Vertical growth (USD QoQ): Healthcare & Insurance +6.8%, Manufacturing & Consumer +3.5%, Banking +3.9%, Professional Services +13.3%, Financial Services +1.1%, Technology Products & Platforms -3.1%, Travel & Transportation -1.0%.
  • · Geographic growth (USD QoQ): Americas +2.9%, Europe +7.0%, Asia Pacific +14.1%.
  • · IT Services & Others grew 5.2% QoQ; BPS Services declined 1.8% QoQ.
  • · CY26 vertical outlook: Healthcare & Insurance, Banking, and Manufacturing & Consumer expected to lead; Travel & Transportation expected to lag.
  • · Awards: Gold Stevie for Fastest Growing Company of the Year 2025; Top Business Transformation Partner of the Year 2026 by Automation Anywhere; Top 25 Most Valuable IT Brands globally by Brand Finance.
Prestige Estates Projects Limited Market Notice neutral materiality 1/10

29-07-2026

Prestige Estates Projects Limited has informed the stock exchanges that its investor presentation for the quarter ended June 30, 2026 (Q1 FY27) has been uploaded on the company's website. The filing is a routine disclosure under SEBI Listing Regulations and does not contain any financial results or performance data.

  • · The investor presentation is available at the weblink: https://d1t2fddy6amcvs.cloudfront.net/investors/financial-performance/fy-2026-2027/Investor-Presentation--Q1-FY27.pdf
  • · The filing is made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
HAMPTON SKY REALTY LIMITED Market Notice negative materiality 9/10

29-07-2026

Hampton Sky Realty Limited disclosed that BSE Limited has directed depositories to freeze the demat accounts of its promoters for debit transactions, effective July 27, 2026, due to the company's failure to submit audited standalone and consolidated financial results for FY ended March 31, 2026 within the prescribed timeline under SEBI Listing Regulations. The company acknowledges the non-compliance and is taking steps to complete the pending filings, but states it does not expect any material financial impact on its business operations from this action. The disclosure itself was delayed as the company assessed the relevance and implications of the freeze order.

  • · The freeze on promoters' demat accounts was communicated by depositories on July 27, 2026, following instructions from BSE Limited.
  • · The non-compliance relates to the non-submission of audited standalone and consolidated financial results for the financial year ended March 31, 2026, under Regulation 33 of SEBI Listing Regulations.
  • · The company's earlier disclosure regarding the non-submission was dated July 1, 2026.
  • · The company admits a minor delay in making this disclosure, citing the need to assess the relevance and implications of the freeze order.
  • · The company states it does not expect any material financial impact on its business operations or other activities due to the freeze.
ADF Foods Limited Market Notice mixed materiality 8/10

29-07-2026

ADF Foods Limited reported Q1 FY27 consolidated revenue of ₹167.3 Cr, up 25.9% YoY, marking the fourth consecutive quarter of double-digit growth. Consolidated EBITDA grew 26.0% to ₹29.7 Cr with margin maintained at 17.7%, while PAT increased 13.4% to ₹17.3 Cr. However, on a sequential basis, all key metrics declined sharply: revenue fell 15.0% QoQ, EBITDA dropped 13.5%, and PAT plunged 33.3%, indicating a significant seasonal slowdown from Q4 FY26. The company also highlighted AEO-T3 certification and commencement of commercial deliveries from its Surat greenfield facility.

  • · Standalone PAT margin declined 180 bps YoY to 15.1% and 490 bps QoQ.
  • · Consolidated PAT margin fell 120 bps YoY to 10.3% and 290 bps QoQ.
  • · The company cited geopolitical uncertainties, West Asia conflict, trade-route disruptions, vessel shortages, and elevated freight costs as headwinds.
  • · Shipping and container constraints limited full conversion of customer demand into revenue.
  • · Commercial deliveries from Surat greenfield facility commenced during the quarter.
OnEMI Technology Solutions Ltd IPO Listing neutral materiality 5/10

29-07-2026

OnEMI Technology Solutions Ltd filed a monitoring agency report from CRISIL for the quarter ended June 30, 2026, confirming that IPO proceeds of ₹8,500.00 million (gross) were utilized as per the offer document. Of the net proceeds of ₹7,940.85 million, ₹7,454.00 million was utilized during the quarter, leaving ₹486.85 million unutilized. The funds were primarily used to augment the capital base of its subsidiary Si Creva Capital Services Private Limited (₹6,368.03 million) and for general corporate purposes (₹1,085.97 million). No deviations or material adverse events were reported.

  • · IPO period was April 30, 2026 to May 5, 2026.
  • · Equity shares were issued; no IPO grading.
  • · No deviation from objects or change in means of finance.
  • · Unutilized proceeds of ₹774.96 million were held in fixed deposits (₹300 million) and various bank accounts.
  • · Interest earned on unutilized proceeds is not part of monitoring scope.
Zee Learn Limited Corporate Governance mixed materiality 8/10

29-07-2026

Zee Learn Limited's Board approved unaudited standalone and consolidated financial results for Q1 FY26 (quarter ended June 30, 2026) and the divestment of its entire 100% stake in wholly owned material subsidiary Liberium Global Resources Private Limited to unrelated third party Creantum Security Solutions Private Limited, subject to shareholder approval. The auditor's review report includes a qualified conclusion due to the absence of impairment assessment on a recoverable amount of ₹79,993.47 lakh from four trusts/entity, and ongoing corporate guarantee defaults by subsidiary Digital Ventures Private Limited. The Liberium subsidiary contributed a turnover of ₹10,490 Lakh (24% of consolidated turnover) but a PAT loss of ₹809 Lakh (negative 21% of consolidated PAT) in FY26, and the divestment consideration is nil upfront.

  • · The Board meeting commenced at 5:15 p.m. and concluded at 6:30 p.m. on July 29, 2026.
  • · The divestment of Liberium is subject to shareholder approval; consideration will be received only after share transfer.
  • · The auditor's qualified conclusion also notes that subsidiary DVPL defaulted on loans from Axis Bank and TMB, leading to CIRP proceedings that were later withdrawn.
  • · The settlement agreement with J.C. Flowers was terminated due to payment delays; the outstanding was assigned to ACRE.
  • · The company has not carried out impairment assessment on the ₹79,993.47 lakh recoverable from four trusts/entity, as required under Ind AS 109.
BGR Energy Systems Limited Market Notice neutral materiality 7/10

29-07-2026

BGR Energy Systems' Board approved unaudited standalone and consolidated financial results for Q1 FY27 (quarter ended June 30, 2026), along with the re-appointment of Mr. Arjun Govind Raghupathy as Managing Director for five years from November 11, 2026. The Board also approved raising up to ₹29 Crore in unsecured loans from the Managing Director and up to ₹150 Crore in loans (secured or unsecured, with conversion rights) from the promoter/promoter group, and the shifting of the registered office from Andhra Pradesh to Tamil Nadu. No financial figures or period-over-period comparisons were disclosed in this filing, so performance trends cannot be assessed.

  • · The Board meeting commenced at 15:45 PM and concluded at 19:30 PM on July 29, 2026.
  • · Mr. Arjun Govind Raghupathy holds 2,220 equity shares (0.00%) as of June 30, 2026.
  • · The re-appointment of Mr. Raghupathy and the shifting of the registered office are subject to shareholder approval at the 40th Annual General Meeting.
  • · The loan from the promoter group includes an option to convert outstanding amounts into equity/preference shares or convertible securities, subject to shareholder and regulatory approvals.
  • · Mr. Rangarajan Mukunthan was appointed as President for Business Division (Senior Management Personnel) effective July 29, 2026.
Shri Venkatesh Refineries Limited Market Update positive materiality 6/10

29-07-2026

Shri Venkatesh Refineries Limited has received trading approval from BSE to migrate from the SME platform to the Main Board, effective July 29, 2026. This milestone enhances the company's visibility and access to a broader investor base. No financial or operational metrics were disclosed in this filing.

  • · Trading approval for migration from BSE SME to Main Board received on July 29, 2026.
  • · The company is now eligible for trading on the BSE Main Board.
Steelcast Limited Corporate Governance neutral materiality 3/10

29-07-2026

Steelcast Limited held its 55th Annual General Meeting (AGM) on July 29, 2026, in physical mode at Bhavnagar, Gujarat. The meeting, which lasted 30 minutes, saw the approval of all seven agenda items, including the adoption of audited financials for FY2025-26, declaration of a final dividend of 54% for FY2025-26 and a first interim dividend of 45% for FY2026-27, and the re-appointment of key directors. The meeting was attended by 32 members, 9 directors, and 20 proxy holders, with the chairman answering member questions to their satisfaction.

  • · The AGM was conducted physically at Efcee Sarovar Premiere, Bhavnagar, Gujarat.
  • · The meeting commenced at 4:30 PM and concluded at 5:00 PM.
  • · All seven resolutions (5 ordinary, 2 special) were passed with requisite majority.
  • · Special resolutions included re-appointment of Chetan M Tamboli as Managing Director and revision of Hemant D Dholakia's term.
  • · The company declared a final dividend of 54% for FY2025-26 and a first interim dividend of 45% for FY2026-27.
ADF Foods Limited Market Notice mixed materiality 8/10

29-07-2026

ADF Foods Limited reported strong Q1 FY27 consolidated results with revenue from operations at INR 167.3 Crore, up 25.9% YoY, EBITDA at INR 29.7 Crore (up 26.0% YoY, margin 17.7%), and PAT at INR 17.3 Crore (up 13.4% YoY). The company highlighted robust performance despite geopolitical headwinds, with flagship brand Ashoka delivering strong diaspora demand and Truly Indian expanding to 3,000+ stores in the US. However, PAT margin declined sequentially from 13.2% in Q4 FY26 to 10.3% in Q1 FY27, and standalone PAT growth of 7.6% YoY lagged revenue growth, reflecting margin pressure from elevated freight costs and operational expenses.

  • · Processed Foods segment revenue grew 47.1% YoY to INR 165.0 Cr, while Distribution segment revenue doubled to INR 40.0 Cr.
  • · Distribution EBITDA margin declined sharply from 17.4% in Q1 FY26 to 11.5% in Q1 FY27.
  • · Standalone PAT margin dropped from 20.0% in Q4 FY26 to 15.1% in Q1 FY27.
  • · Surat greenfield facility commenced commercial deliveries and initial container shipments in Q1 FY27.
  • · Company expects FY27 revenue upwards of INR 900 Crore, with capacity available for INR 180-200 Cr at current levels and INR 250-275 Cr after greenfield expansion.
  • · AEO-T3 certification achieved to streamline export customs clearances.
  • · Company maintains net debt-free status.
Rainbow Childrens Medicare Limited Merger/Acquisition mixed materiality 8/10

29-07-2026

Rainbow Children's Medicare Limited (RCML) has executed definitive transaction documents to develop a new 100-bed children's and women's hospital in Malad, Mumbai through its subsidiary RWCHPL, with an estimated project cost of approximately ₹90 Crore. As part of the deal, RCML will dilute a 24% equity stake in RWCHPL to Fountainhead TCHM Healthcare LLP (promoted by three doctors), reducing its holding from 100% to 76% while retaining control. The hospital is expected to be commissioned by Q1 FY27-28, complementing a previously announced 150-bed Pune facility to build a hub-and-spoke network in Maharashtra. However, the subsidiary RWCHPL has negligible turnover (₹0.006 Crore in FY24-25 and ₹0.008 Crore in FY23-24) and a negative net worth of ₹(0.003) Crore, and the company's overall bed utilisation stands at only 46.3%.

  • · RWCHPL's turnover declined 25% from ₹0.008 Crore in FY23-24 to ₹0.006 Crore in FY24-25.
  • · RWCHPL has a negative net worth of ₹(0.003) Crore as of March 31, 2026.
  • · The Malad hospital is a brownfield project expected to commence operations in Q1 FY28, while the Pune hub is expected in FY29.
  • · RCML's existing bed utilisation is only 46.3% despite 2,435 beds.
  • · The consideration for the 24% stake sale is only ₹24,000, indicating a nominal valuation for the subsidiary.
Dr. Reddy's Laboratories Limited Market Notice negative materiality 6/10

29-07-2026

Dr. Reddy's Laboratories received a Form 483 with three observations from the USFDA following a Pre-Approval Inspection (PAI) and GMP inspection at its FTO-SEZ Process Unit-02 in Srikakulam, Andhra Pradesh, conducted from July 20 to July 29, 2026. The company has stated it will address the observations within the stipulated timeline. While the issuance of a Form 483 is not uncommon, the presence of three observations may indicate compliance gaps that could delay product approvals or lead to further regulatory scrutiny.

  • · The inspection was a Pre-Approval Inspection (PAI) and GMP inspection at the FTO-SEZ Process Unit-02 in Srikakulam, Andhra Pradesh.
  • · The inspection duration was from July 20, 2026, to July 29, 2026.
  • · The company will address the three observations within the stipulated timeline.
ICSA (India) Ltd-$ Insolvency negative materiality 9/10

29-07-2026

ICSA (India) Ltd filed belated financial results for periods from FY2019-20 to FY2022-23, following the NCLT-ordered liquidation and subsequent closure of liquidation proceedings. The company reported persistent losses with zero revenue across all periods, with net losses widening from ₹558.81 Lakh in Q2 FY2020 to ₹4,869.76 Lakh in Q3 FY2020. The liquidation process realized ₹10,23,89,263 from asset sales, including ₹900.00 Lakh from land sold to Hyderabad Bottling Company, and the NCLT ordered closure of liquidation on February 7, 2023.

  • · NCLT Hyderabad Bench ordered liquidation on August 18, 2020, and appointed Mr. Nethi Mallikarjuna Setty as Liquidator.
  • · The liquidator was never provided control of documents by the erstwhile management, leading to accounts prepared based on available alternate evidence.
  • · NCLT ordered closure of liquidation on February 7, 2023, via IA No. 215 of 2023, after sale of the corporate debtor as a going concern.
  • · The newly appointed Board of Directors disclaims responsibility for financial oversight prior to acquisition.
  • · The filing covers financial results for FY2019-20 through FY2022-23, all showing zero revenue and consistent losses.
Novartis India Limited. Market Notice positive materiality 9/10

29-07-2026

ChrysCapital has acquired a controlling 70.68% stake in Novartis India Limited (NIL), a BSE-listed Indian pharmaceutical company previously held by Novartis AG. Dr. Vikas Gupta has been appointed as Managing Director and CEO, and Ramesh Ramadurai, Suchita Sharma, and Shashank Sinha have joined as Independent Directors, with Ramadurai as Chairperson. NIL will adopt a new name and corporate identity to mark the separation from its previous owners.

  • · This is ChrysCapital's first majority-controlled investment in the Indian pharmaceutical sector.
  • · ChrysCapital has raised ~$8.5 billion across 10 private equity funds, a continuation fund, and a public markets fund.
  • · ChrysCapital has invested over $5.6 billion in more than 110 deals and realized almost $8 billion from 80+ exits.
Adani Power Limited Company Update positive materiality 9/10

30-07-2026

Adani Power reported its highest-ever quarterly performance for Q1 FY27, with total continuing revenue of INR17,936 crore (+27% YoY), continuing EBITDA of INR6,983 crore (+22% YoY), and PAT of INR4,867 crore (+47% YoY). Operational highlights included record power generation of 31 billion units and a PLF of 78% (vs 67% last year). However, merchant volumes declined to 4 billion units from 6 billion units YoY as capacity was increasingly tied up under PPAs, and fuel costs rose 30% to INR9,513 crore. The company also completed the acquisition of Jaiprakash Associates' power assets and signed a 25-year PPA with Maharashtra DISCOM for 1,600 MW.

  • · India's peak power demand reached a record ~271 GW in May 2026.
  • · Overall energy consumption rose 8.4% YoY to 485 billion units in Q1 FY27.
  • · PPA tariff realization improved 8% to INR5.93/unit; merchant realization improved 13% to INR7.04/unit.
  • · Adani Power was ranked India's most valued energy brand by Brand Finance with a brand value of USD1.8 billion and AAA rating.
  • · The company has ordered the entire 24 GW of BTG supply in advance and secured land for expansion.
  • · Korba Phase-II (1,320 MW) is on track for commissioning this year; Mahan Phase-II (1,600 MW) scheduled for Q1 FY28.
  • · Raipur Phase-II and Raigarh Phase-II have achieved over 62% and 54% progress, respectively.
  • · The company is evaluating both domestic and foreign nuclear technologies, but final decisions await government rules under the Act.
  • · The 24% stake in JPVL is accounted as an associate (only share of profit consolidated).
Mangalam Cement Limited Market Update neutral materiality 1/10

29-07-2026

Mangalam Cement Limited has filed its 50th Annual Report and Notice of AGM for FY2025-26 with the stock exchanges. The AGM will be held on August 21, 2026, via video conferencing. The filing is a routine regulatory disclosure and does not contain any financial results or material business updates.

  • · The 50th AGM will be held on Friday, 21st August 2026 at 2:00 PM IST through VC/OAVM.
  • · Cut-off date for e-voting and record date is Friday, 14th August 2026.
  • · Remote e-voting runs from 9:00 AM IST on 18th August 2026 to 5:00 PM IST on 20th August 2026.
  • · The Annual Report and Notice are available on the company's website.
  • · Board of Directors includes 8 members: Chairman, 2 Non-Independent Directors, 5 Independent Directors, and 1 Executive Director.
  • · Key Managerial Personnel: Chairman & Whole Time Director, Executive Director & CFO, and Company Secretary.
  • · The company has three plant locations: Rajasthan (Morak), Odisha (Kusumi), and Uttar Pradesh (Aligarh).
  • · Auditors: Singhi & Co., Chartered Accountants.
  • · Registrar & Share Transfer Agent: M/s. MAS Services Ltd.
LG Electronics India Limited Corporate Governance neutral materiality 3/10

29-07-2026

LG Electronics India Limited has issued the notice for its 29th Annual General Meeting (AGM) to be held on August 21, 2026, via video conferencing. The meeting will consider the adoption of audited financial statements for FY 2025-26, re-appointment of director Hong Ju Jeon, appointment of Deloitte Haskins & Sells as statutory auditors for five years at a remuneration of ₹1.68 crore, ratification of cost auditor's remuneration of ₹2,50,000, and appointment of secretarial auditors for five years. The filing is procedural and does not disclose any financial performance metrics or period-over-period comparisons.

  • · AGM date: August 21, 2026 at 11:00 AM IST via VC/OAVM
  • · Remote e-voting period: August 18, 2026 (9:00 AM IST) to August 20, 2026 (5:00 PM IST)
  • · Cut-off date for voting eligibility: August 14, 2026
  • · Director Hong Ju Jeon retires by rotation and offers himself for re-appointment
  • · Deloitte Haskins & Sells appointed as statutory auditors for 5 years (until AGM 2031)
  • · Cost auditor M/s J.K. Kabra & Co. remuneration of ₹2,50,000 for FY 2026-27
  • · Secretarial auditor M/s Dhananjay Shukla & Associates appointed for 5 years (FY 2026-27 to 2030-31)
  • · Annual Report for FY 2025-26 sent electronically to members with registered email IDs
Netweb Technologies India Limited Analyst/Investor Meet neutral materiality 1/10

29-07-2026

Netweb Technologies India Limited has informed the stock exchanges that its senior management will hold in-person meetings with institutional investors and analysts from August 4 to August 7, 2026. The discussions will be based on publicly available information and no unpublished price-sensitive information will be shared.

  • · Meetings will be held in-person on a one-to-one basis across various locations.
  • · The schedule is subject to change due to exigencies on the part of investors, analysts, or the company.
OnEMI Technology Solutions Ltd Market Update neutral materiality 3/10

29-07-2026

OnEMI Technology Solutions Ltd (formerly Kissht) has disclosed its Key Performance Indicators (KPIs) for the quarter ended June 30, 2026, as required under its IPO prospectus. The KPIs are available on the company's investor relations website. No specific financial figures or performance trends were provided in the filing itself.

  • · The KPI disclosure is in compliance with the Prospectus dated May 05, 2026.
  • · The filing does not contain any numerical data; all KPIs are hosted on the company's website.
Rainbow Childrens Medicare Limited Market Update mixed materiality 7/10

29-07-2026

Rainbow Children’s Medicare Limited (RCML) has executed definitive transaction documents to induct Fountainhead TCHM Healthcare LLP into its wholly owned subsidiary Rainbow Women & Children's Hospital Private Limited (RWCHPL), with the LLP to acquire a 24% equity stake and RCML retaining 76% control. The company plans a capacity addition of 100 beds at a new children’s and women’s hospital in Malad, Mumbai, involving an estimated project cost of approximately ₹90 Crore, of which ₹68,40,00,000 will be contributed by RCML; existing capacity is 2,435 beds with utilisation at 46.3%. However, the target company RWCHPL has negligible historical turnover (Nil in FY 25-26; ₹0.006 Crore in FY 24-25; ₹0.008 Crore in FY 23-24), meaning the investment is in capacity/expansion rather than an income-generating asset today.

  • · RCML will fund the project primarily via Internal Accruals (mode of financing).
  • · Proposed commissioning/completion timeline: commissioned by Q1 FY27-28 and on or before Q1 FY27-28 commencement of proposed hospital (Annexure A and C).
  • · Expected date of completion of sale/disposal (transfer formalities): On or before August 31, 2026 (Annexure B).
  • · Post-transaction shareholding in RWCHPL: Rainbow Children’s Medicare Limited - 7,600 shares (76%); Fountainhead TCHM Healthcare LLP - 2,400 shares (24%).
  • · The transaction is disclosed as arm's length and the buyer does not belong to promoter/promoter group/group companies.
  • · The investment will be made in multiple tranches as may be mutually agreed based on funding requirements.
Rainbow Childrens Medicare Limited Market Notice positive materiality 6/10

29-07-2026

Rainbow Childrens Medicare Ltd. reported its unaudited standalone financial results for the quarter and nine months ended December 31, 2024. Total income for Q3 FY25 stood at ₹7,854 Lakhs, up 10.8% from ₹7,087 Lakhs in Q3 FY24. Net Profit After Tax rose 32.2% YoY to ₹2,006 Lakhs from ₹1,517 Lakhs. However, for the nine-month period, total income grew only 5.3% YoY to ₹22,082 Lakhs, while net profit increased 27.8% to ₹5,652 Lakhs. The company’s basic earnings per share for Q3 improved to ₹11.51 from ₹8.71 in the prior year quarter.

  • · Basic EPS for Q3 FY25 stood at ₹11.51 vs ₹8.71 in Q3 FY24.
  • · Total comprehensive income for Q3 FY25 was ₹1,999 Lakhs vs ₹1,511 Lakhs YoY.
  • · The results were reviewed by the Audit Committee and approved by the Board on February 10, 2025.
  • · Previous year figures for Q3 and 9M periods were regrouped where necessary to make them comparable.
Lemon Tree Hotels Limited Market Notice positive materiality 5/10

29-07-2026

Lemon Tree Hotels Limited announced the signing of two new license agreements: a Lemon Tree Hotel in Siddharthanagar, Nepal (120 rooms) and a Keys Select by Lemon Tree Hotels in Vijayawada, Andhra Pradesh (70 rooms). Both properties will be managed by its wholly-owned subsidiary, Carnation Hotels Private Limited. The signings expand the group's portfolio to eight properties in Nepal and eleven in Andhra Pradesh, reinforcing its domestic and international growth strategy.

  • · Bhairahawa Airport is approximately 2 km from the Siddharthanagar hotel.
  • · Vijayawada Airport is approximately 19 km from the Vijayawada hotel; Vijayawada Railway Station is just 1.5 km away.
  • · Lemon Tree Hotels operates seven distinct brands: Aurika Hotels & Resorts, Lemon Tree Premier, Lemon Tree Hotels, Red Fox, Keys Prima, Keys Select, and Keys Lite.
  • · The group has an international presence in Bhutan and Nepal.
Waaree Energies Limited Market Update negative materiality 3/10

29-07-2026

Waaree Energies Limited reported a violation of its Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015. On July 8, 2026, during a trading window closure period, 149 equity shares pledged by Designated Person Ankit Ozarker (General Manager, Production Planning) were invoked by a financial institution due to a margin shortfall. The company issued a written warning to Mr. Ozarker, noting the invocation was involuntary, involved an immaterial quantity of shares (valued at approximately ₹4.21 lacs), and there was no intent to violate insider trading rules.

  • · The violation occurred during a trading window closure period.
  • · The pledged shares were invoked due to a shortfall or non-payment of margin requirement on a loan secured by the pledge.
  • · The company determined the invocation was not a voluntary trade by the designated person.
  • · No previous instances of violations have been recorded since the last financial year.
  • · No amount was collected for the Code of Conduct violation.
OnEMI Technology Solutions Ltd Market Notice mixed materiality 9/10

29-07-2026

OnEMI Technology Solutions Ltd (Kissht) reported strong Q1FY27 results with AUM expanding 61% YoY to ₹8,001 Cr and PAT up 59% YoY to ₹95 Cr. The company completed its IPO in May 2026, listing on NSE and BSE, and infused ~₹637 Cr of primary proceeds into its NBFC subsidiary. However, asset quality showed a modest sequential deterioration with GNPA increasing 13 bps QoQ to 2.25% and NNPA rising 6 bps to 0.36%, while unsecured personal loans still dominate the portfolio at 92.3% of AUM.

  • · Unsecured PL constitutes 92.3% of AUM (₹7,384 Cr), while secured LAP is only 7.7% (₹617 Cr).
  • · Off-book AUM of ₹4,284 Cr represents 53.6% of total AUM, sourced through 8 partners.
  • · Stage 3 PCR is 84.13%; ECL coverage on Stage 2 assets improved to 80.44% from 75.58% in Q4FY26.
  • · CRAR stands at 40.2% with Tier-1 at 39.2%; D/E ratio is 0.91x.
  • · Credit rating: A-/Stable.
  • · IPO listing premium was 11.7% over the upper price band; overall subscription 9.9x (QIB 25.9x).
  • · Approximately 75% of primary issue proceeds (~₹637 Cr) infused into NBFC subsidiary Si Creva Capital Services as of May 16, 2026.
PCBL Chemical Limited Analyst/Investor Meet neutral materiality 1/10

29-07-2026

PCBL Chemical Limited has informed the stock exchanges that the audio link for its Q1 FY27 results conference call, held on July 29, 2026, is now available on the company's website. The call covered the financial results for the quarter ended June 30, 2026. No financial figures or performance details were disclosed in this filing.

  • · The conference call was held on July 29, 2026 at 17:00 hrs India Time.
  • · The audio link is available at www.pcblltd.com/investor-relation/financials/investor-presentation.
Bajaj Housing Finance Limited Analyst/Investor Meet neutral materiality 3/10

29-07-2026

Bajaj Housing Finance Limited held a conference call on July 29, 2026, to discuss its financial results for the quarter ended June 30, 2026. The presentation and audio recording have been made available to exchanges and on the company's website. No specific financial figures or performance metrics were disclosed in this filing.

  • · Conference call was held on July 29, 2026, at 18:30 IST.
  • · Audio recording is available at https://www.bajajhousingfinance.in/investor-presentation.
  • · Presentation was shared with exchanges on the same date.
Midland Polymers Ltd. Corporate Governance positive materiality 8/10

29-07-2026

Midland Polymers Ltd. has completed the acquisition of a 70% stake in JMRCLEAN Energy Private Limited via a share swap, allotting 73,78,350 equity shares at ₹10 each. The board also approved preferential allotments of 79,73,518 equity shares for cash and 91,00,000 convertible warrants, raising additional capital. While the acquisition expands Midland's presence in the renewable energy sector, the target company's turnover surged from ₹17.50 Lakh in FY2024-25 to ₹7,139.61 Lakh in the first nine months of FY2025-26, indicating a very high growth trajectory but also a very short operating history (incorporated in December 2024).

  • · The acquisition was executed via a share swap: 73,78,350 Midland equity shares (₹10 each) were exchanged for 7,00,000 equity shares of JMRCLEAN (70% stake).
  • · Preferential allotment for cash: 79,73,518 equity shares at ₹10 each, raising ₹7,97,35,180 from six allottees, including one promoter (Gudapu Reddy Sreedar Reddy – 24,00,000 shares).
  • · Convertible warrants: 91,00,000 warrants at ₹10 each were allotted to eight allottees, with 25% upfront payment (₹2,27,50,000) received.
  • · JMRCLEAN Energy was incorporated on 17/12/2024 and has a very short operating history; its turnover jumped from ₹17.50 Lakh in FY2024-25 to ₹7,139.61 Lakh in the nine months ended 31.12.2025.
  • · JMRCLEAN claims an order book of ₹1,550 crore and a 400 MW pipeline, with over 100 MW of projects already executed.
  • · The acquisition is not a related party transaction.
  • · No governmental or regulatory approvals were required for the acquisition.

Get daily alerts with 10 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: India Pre-Market Regulatory Roundup

🇮🇳 More from India

View all →